Valuation: Omnicell, Inc.

Market Cap 1.61B 1.4B 1.31B 1.2B 2.26B 153B 2.3B 15.39B 6.03B 76.46B 6.04B 5.91B 252B P/E 2026 *
36x
P/E 2027 * 34.9x
Enterprise Value 1.61B 1.4B 1.31B 1.2B 2.26B 153B 2.3B 15.39B 6.03B 76.46B 6.04B 5.91B 252B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.25x
Free-Float
76.27%
Yield 2026 *
-
Yield 2027 * -
1 day+6.05%
1 week-9.46%
Current month+6.21%
1 month-16.97%
3 months-13.52%
6 months-18.41%
Current year-17.08%
1 week 34.86
Extreme 34.86
44.27
1 month 34.86
Extreme 34.86
48.06
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Sell

Chief Executive Officer

-10,000 0.0220%
1/7/26 Free

Chairperson

12,309 0.0271%
1/4/26 Free

Chief Administrative Officer

25,132 0.0553%
Change 5-day change 1-year change 3-year change Capi.($)
+6.09%-9.46%+23.49%-41.19% 1.61B
+1.11%+6.66%-27.29%+6.61% 33.1B
+1.53%+3.05%-47.55%+131.70% 11.9B
+0.30%-1.25%-23.82%+65.23% 5.4B
+6.16%+7.02% - - 2.18B
+2.46%+3.87% - - 1.79B
+0.88%+2.93%-31.47% - 1.05B
+0.12%-0.68%+31.14%+112.62% 857M
+0.84%+13.92%-39.50%-49.22% 819M
+0.38%+1.14%+504.55%+786.67% 688M
Average +2.00%+1.58%+48.69%+144.63% 5.94B
Weighted average by Cap. +1.47%+5.66%-22.59%+49.08%

Financials

2026 *2027 *
Net sales 1.24B 1.08B 1B 921M 1.74B 118B 1.77B 11.83B 4.63B 58.79B 4.65B 4.54B 194B 1.29B 1.12B 1.05B 960M 1.81B 123B 1.84B 12.33B 4.83B 61.24B 4.84B 4.73B 202B
Net income 45.27M 39.35M 36.74M 33.72M 63.59M 4.32B 64.7M 433M 170M 2.15B 170M 166M 7.1B 47.37M 41.17M 38.43M 35.28M 66.53M 4.51B 67.69M 453M 177M 2.25B 178M 174M 7.43B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,580
Date Price Change Volume
04/08/26 US$37.58 +6.25% 799,480
31/07/26 US$35.37 -4.69% 1,121,366
30/07/26 US$37.11 -10.36% 2,045,703
29/07/26 US$41.40 -3.83% 1,309,511
28/07/26 US$43.05 +3.76% 753,773
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
35.37USD
Average target price
57.86USD
Spread / Average Target
+63.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock